A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

NCT04633252 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

86

Enrollment

NIH

Sponsor class

Conditions

Cancer Of Prostate
Prostate Neoplasms

Interventions

DRUG: PDS01ADC
DRUG: Docetaxel
DRUG: M7824
DRUG: Prednisone
DRUG: ADT

Sponsor

National Cancer Institute (NCI)